Showing results (261-270 of 523) with videos related to

Sort By:
Pageof 53
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 24, 2012
Effect of chemotherapy in patients with resected small-cell or large-cell neuroendocrine carcinomaNader Abedallaa, Lise Tremblay, Charlotte Baey, et al.
Ecancermedicalscience|October 21, 2020
Perspectives on cancer care in older patients in FranceMathilde Hauchecorne, Monica Pierro, Etienne Brain, et al.
Future Oncology (London, England)|August 11, 2022
LIBRETTO-432, a phase III study of adjuvant selpercatinib or placebo in stage IB-IIIA RET fusion-positive non-small-cell lung cancerMasahiro Tsuboi, Jonathan W Goldman, Yi-Long Wu, et al.
Future Oncology (London, England)|June 22, 2021
First-line pembrolizumab with or without platinum doublet chemotherapy in non-small-cell lung cancer patients with PD-L1 expression ≥50Renaud Descourt, Christos Chouaid, Maurice Pérol, et al.
European Journal of Cancer (Oxford, England : 1990)|July 28, 2026
Validation of the lung immune prognostic index in extensive-stage small cell lung cancer: Post hoc analysis of the caspian and IMpower133 phase 3 trialsEdouard Auclin, Matthieu Roulleaux Dugage, Teresa Gorría, et al.
Lung Cancer (Amsterdam, Netherlands)|April 2, 2021
Pleural effusion is a negative prognostic factor for immunotherapy in patients with non-small cell lung cancer (NSCLC): The pluie studyNicolas Epaillard, Jose Carlos Benitez, Teresa Gorria, et al.
Oncotarget|April 28, 2017
Prognostic value of tumor mutations in radically treated locally advanced non-small cell lung cancer patientsAngela Boros, Ludovic Lacroix, Benjamin Lacas, et al.
European Radiology|May 15, 2021
Can MRI differentiate surrounding vertebral invasion from reactive inflammatory changes in superior sulcus tumor?Fadila Mihoubi Bouvier, Vincent Thomas De Montpréville, Benjamin Besse, et al.
Nature Communications|September 2, 2021
Integrin-αV-mediated activation of TGF-β regulates anti-tumour CD8 T cell immunity and response to PD-1 blockadeInes Malenica, Julien Adam, Stéphanie Corgnac, et al.
Lung Cancer (Amsterdam, Netherlands)|September 15, 2019
Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group surveyAntonin Levy, Lizza E L Hendriks, Cécile Le Péchoux, et al.
Pageof 53